Page 6 - Sameer Patel News Today

A Nevada democracy watchdog group said social media, blogs, websites and hyperpartisan news organizations are all working overtime to spread disinformation in an effort to influence the midterm elections in November. One debunked claim said voting machine algorithms are changing votes, which has driven two Nevada counties to move to hand-count their ballots, a much less secure process, and more vulnerable to manipulation. Lisa Lynn Chapman, Nevada disinformation state manager at the Institute ...

As the midterm elections approach, there are concerns about whether Latino voters will turn out as much as they have in past elections. In New York, 12% of voters in the 2020 General Election were Latino, up from 10% in 2018, according to a poll by Univision, including a lot of new and young voters. Ameer Patel, vice president of programs for the group Voto Latino, pointed out with such divisive issues as abortion access, gun restrictions, the economy and democracys integrity on the ballot thi...

A new study shows that Latino voters were becoming targets of ad campaigns from both Republicans and Democratic as the November midterm elections get near.

Non-profit Voto Latino aims to challenge Republican ‘disinformation’ in key battleground states

Latinos support reproductive rights by large margins – and that could prove a powerful mobilizing tool in the midterms

SAP CX didn't get the main stage time at SAP Sapphire Orlando, but behind the scenes, spirited discussions took place. Grab your summer beverage of choice, and check out what I learned from these debates - as well as my first sit-down with Ritu Bhargava, President & Chief Product Officer, CX/CRM at SAP.

I've been tracking SAP CX moves across leadership changes. Now, the week before SAP's Sapphire events, it's time for an update and preview. SAP's Jen Bailin joined me to share her views, including her take on the relevance of the metaverse.

Pearl de la Motte exceptional soloist for Higdon's Viola Concerto

“We’re really thankful we now have this additional tool to protect those that really suffer greatly.”

Evusheld, authorized by the Food and Drug Administration for emergency use in December, joins a slate of other COVID-19 treatments available to people at high risk of death or hospitalization,